Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06079424

Risk Markers of Arterial Aging. The Paris Prospective Study III-2

Risk Markers of Arterial Aging and Subsequent Risk of Cardiovascular Diseases and Beyond. The Paris Prospective Study III-2

Status
Recruiting
Phase
Study type
Observational
Enrollment
7,500 (estimated)
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France · Other Government
Sex
All
Age
60 Years – 95 Years
Healthy volunteers
Accepted

Summary

The main objectives of PPS3-2 are (i) to describe the dynamics of vascular aging and baroreflex sensitivity 12 to 16 years a part, (ii) to identify their determinants, and (iii) to quantify the subsequent risk of cardiovascular diseases.

Detailed description

Since May 2008, PPS3 is being following the CVD morbidity of 10157 healthy volunteers aged 50-75 years at baseline. In PPS3-2, we plan to re-invite survivors and volunteers of PPS3 to undergo a second physical examination. In particular, they will undergo a second high-precision carotid echotracking to measure vascular aging parameters and baroreflex sensitivity, permitting to study their respective dynamics. They will also underwent for the first time ultra fast echo of the radial artery to measure vascular aging parameters of the medium-sized arteries. According to fundings, blood samples will be taken and stored at -80°C in the whole population or in a subsample.

Conditions

Interventions

TypeNameDescription
OTHERhigh-precision carotid echo-trackingevaluation of vascular aging parameters and baroreflex sensitivity

Timeline

Start date
2025-06-20
Primary completion
2031-05-01
Completion
2033-12-01
First posted
2023-10-12
Last updated
2025-09-11

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06079424. Inclusion in this directory is not an endorsement.